Nilam Soni

Dr. Nilam Soni

University of Texas Health Science Center at San Antonio
+1
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
AMAnna Maw
Anna Maw
AHAhmed Hassanin
Ahmed Hassanin
PHP. Michael Ho
P. Michael Ho
MMMatthew D. F. McInnes
Matthew D. F. McInnes
AMAngela Moss
Angela Moss
SDStacie L. Daugherty
Stacie L. Daugherty
Acute decompensated heart failure (ADHF) is the primary cause in up to 40% of older adults presenting with dyspnea,1 one of the leading reasons for emergency department visits in the United States.2 The diagnostic workup for ADHF can be challenging and often requires several tests. The insensitivity of guideline-recommended tools for diagnosing ADHF, such as chest radiography (CXR), physical examination, and brain-type natriuretic peptide (BNP),3,4 is known to delay treatment, which is associated with an increase in mortality.5,6 In particular, the sensitivity of CXR in detecting pulmonary edema is limited, with 20% being a false-negative.7,8 Given the limitations of current tools to diagnose ADHF, the National Heart, Lung, and Blood Institute Working Group on Emergency Department Management of Acute Heart Failure has prioritized the development of new techniques for the diagnosis and monitoring of ADHF.9

1 December 2016 in Mayo Clinic Proceedings
Verified
Journal Article
Closed access
ABAnjali Bhagra
Anjali Bhagra
DTDavid Tierney
David Tierney
HSHiroshi Sekiguchi
Hiroshi Sekiguchi
Nilam SoniNilam Soni
Nilam Soni

28 July 2015 in Journal of Hospital Medicine
Verified
Journal Article
Closed access
PDF file
Nilam SoniNilam Soni
Nilam Soni
RFRicardo Franco
Ricardo Franco
MVMaria I. Velez
Maria I. Velez
DSDaniel Schnobrich
Daniel Schnobrich
RDRia Dancel
Ria Dancel
PMPaul H. Mayo
Paul H. Mayo

5 July 2018 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
MRMarcos I. Restrepo
Marcos I. Restrepo
BBBettina L. Babu
Bettina L. Babu
LRLuis F. Reyes
Luis F. Reyes
JCJames D. Chalmers
James D. Chalmers
Nilam SoniNilam Soni
Nilam Soni
SAStefano Aliberti
Stefano Aliberti
Pseudomonas aeruginosais a challenging bacterium to treat due to its intrinsic resistance to the antibiotics used most frequently in patients with community-acquired pneumonia (CAP). Data about the global burden and risk factors associated withP. aeruginosa-CAP are limited. We assessed the multinational burden and specific risk factors associated withP. aeruginosa-CAP.We enrolled 3193 patients in 54 countries with confirmed diagnosis of CAP who underwent microbiological testing at admission. Prevalence was calculated according to the identification ofP. aeruginosa. Logistic regression analysis was used to identify risk factors for antibiotic-susceptible and antibiotic-resistantP. aeruginosa-CAP.The prevalence ofP. aeruginosaand antibiotic-resistantP. aeruginosa-CAP was 4.2% and 2.0%, respectively. The rate ofP. aeruginosaCAP in patients with prior infection/colonisation due toP. aeruginosaand at least one of the three independently associated chronic lung diseases (i.e.tracheostomy, bronchiectasis and/or very severe chronic obstructive pulmonary disease) was 67%. In contrast, the rate ofP. aeruginosa-CAP was 2% in patients without priorP. aeruginosainfection/colonisation and none of the selected chronic lung diseases.The multinational prevalence ofP. aeruginosa-CAP is low. The risk factors identified in this study may guide healthcare professionals in deciding empirical antibiotic coverage for CAP patients.

1 December 2016 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
SAStefano Aliberti
Stefano Aliberti
LRLuis F Reyes
Luis F Reyes
Paola FaverioPaola Faverio
Paola Faverio
GSGiovanni Sotgiu
Giovanni Sotgiu
SDSimone Dore
Simone Dore
LLLucía Labra
Lucía Labra

2 January 2019 in Journal of Hospital Medicine
Verified
Journal Article
Open access
PDF file
Nilam SoniNilam Soni
Nilam Soni
DSDaniel Schnobrich
Daniel Schnobrich
BMBenji K. Mathews
Benji K. Mathews
DTDavid Tierney
David Tierney
TJTrevor P. Jensen
Trevor P. Jensen
BLBrian P. Lucas
Brian P. Lucas
Many hospitalists incorporate point‐of‐care ultrasound (POCUS) into their daily practice to answer specific diagnostic questions or to guide performance of invasive bedside procedures. However, standards for hospitalists in POCUS training and assessment are not yet established. Most internal medicine residency training programs, the major pipeline for incoming hospitalists, have only recently begun to incorporate POCUS in their curricula. The purpose of this document is to inform a broad audience on what POCUS is and how hospitalists are using it. This document is intended to provide guidance for the hospitalists who use POCUS and administrators who oversee its use. We discuss POCUS 1) applications, 2) training, 3) assessments, and 4) program management. Practicing hospitalists must continue to collaborate with their local credentialing bodies to outline requirements for POCUS use. Hospitalists should be integrally involved in decision‐making processes surrounding POCUS program management.